The Food and Drug Administration said Tuesday that it approved Merck & Co.’s (MRK) drug Januvia to treat type 2 diabetes.
Januvia is the first in a new class of diabetes medicine known as DPP-4 inhibitor. The drug works by enhancing the body’s own ability to lower blood sugar, or glucose, when it is elevated. >>
